Darby Miller is an Ophthalmology physician. OpenAlex indexes 49 publications with 682 citations (h-index 11).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4500 San Pablo Rd S
Jacksonville, FL 322241865
Telephone
904-953-2000Provider last certified this registry record 28 Aug 2020.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Siemens Medical Solutions USA, Inc.Program year20251 payment
- GLAUKOS CORPORATIONProgram year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
61.8%Corticosteroid25.2%Prednisolone Acetate84%Fluorometholone17%Part D≥108 patientsAminoglycoside Antibacterial8.2%Tobramycin-Dexamethasone76%Tobradex24%Part D<11 patients+ 6 more classes in this area
Anti-infectives
32.9%Fluoroquinolone Antibacterial12.7%Moxifloxacin100%Part D≥86 patientsHerpesvirus Nucleoside Analog DNA Polymerase Inhibitor10.1%Valacyclovir100%Part D≥27 patients+ 3 more classes in this area
Musculoskeletal
2.7%Cyclooxygenase Inhibitor2.7%Ketorolac Tromethamine100%Part D≥18 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Risk of Glaucoma Progression in Patients Using a Calcium Channel Blocker: A Propensity-Matched Cohort Study
Investigative Ophthalmology & Visual Science
2026 - Low-Dose Valacyclovir for Postherpetic Neuralgia in the Zoster Eye Disease Study
JAMA Ophthalmology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Emily Chew, MD
National Eye Institute
Robert Weinreb, MD
University of California San Diego
Harry Quigley, MD
Johns Hopkins University School of Medicine
Joel Schuman, MD
Wills Eye Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”